132 related articles for article (PubMed ID: 3136464)
1. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
Loosen PT; Marciniak R
Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine abnormalities in affective disorders.
Extein I; Pottash AL; Gold MS
Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
[TBL] [Abstract][Full Text] [Related]
4. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
[TBL] [Abstract][Full Text] [Related]
5. Biological markers of melancholia and reclassification of depressive disorders.
Greden JF
Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
[TBL] [Abstract][Full Text] [Related]
6. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
Chen G
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
[TBL] [Abstract][Full Text] [Related]
7. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
[TBL] [Abstract][Full Text] [Related]
8. Pituitary sensitivity to thyroid hormones in depressed patients.
Loosen PT; Garbutt JC; Dew B; Prange AJ
Pharmacopsychiatry; 1987 May; 20(3):85-9. PubMed ID: 3110799
[TBL] [Abstract][Full Text] [Related]
9. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
Targum SD
Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
[TBL] [Abstract][Full Text] [Related]
10. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
[TBL] [Abstract][Full Text] [Related]
11. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
Targum SD
Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
[TBL] [Abstract][Full Text] [Related]
12. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
13. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
[No Abstract] [Full Text] [Related]
14. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
Cervera S
Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
[TBL] [Abstract][Full Text] [Related]
15. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
Poirier MF; Lôo H; Lefur G; Mitrani N
Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
[TBL] [Abstract][Full Text] [Related]
16. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
Zhou DF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
[No Abstract] [Full Text] [Related]
17. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
[TBL] [Abstract][Full Text] [Related]
18. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
[TBL] [Abstract][Full Text] [Related]
19. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Meltzer HY; Lowy MT; Locascio JJ
Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
[TBL] [Abstract][Full Text] [Related]
20. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
